Skip to Content



In This Issue

October 2014, Volume 59, Issue 10  

New Drugs for Myeloproliferative Neoplasms Ease Suffering and Extend Life
JAK2 inhibitors and other treatments improve quality of life
Neoadjuvant Targeted Therapy May Offer Multiple Benefits for Patients with Locally Advanced Renal Cancer
Targeted drugs may offer multiple benefits
New Combination Therapy Offers Potential to Cure FLT3-ITD Acute Myelogenous Leukemia
Clinical trial results are promising
House Call: Symptoms of Cancer
Lasting symptoms can mean cancer or other diseases

View entire issue as PDF

Follow us on Twitter

OncoLog en Español

OncoLog, October 2014, Volume 59, Issue 10